Florian Slimano

525 total citations
47 papers, 274 citations indexed

About

Florian Slimano is a scholar working on Oncology, Geriatrics and Gerontology and Molecular Biology. According to data from OpenAlex, Florian Slimano has authored 47 papers receiving a total of 274 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 15 papers in Geriatrics and Gerontology and 7 papers in Molecular Biology. Recurrent topics in Florian Slimano's work include Pharmaceutical Practices and Patient Outcomes (14 papers), Patient Safety and Medication Errors (4 papers) and Nausea and vomiting management (3 papers). Florian Slimano is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (14 papers), Patient Safety and Medication Errors (4 papers) and Nausea and vomiting management (3 papers). Florian Slimano collaborates with scholars based in France and Austria. Florian Slimano's co-authors include Céline Mongaret, Olivier Bouché, Damien Botsen, Charles Saby, Hamid Morjani, Marine Perrier, Mathias Brügel, Lukshe Kanagaratnam, Pierrick Bedouch and Moustapha Dramé and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nutrients and International Journal of Environmental Research and Public Health.

In The Last Decade

Florian Slimano

40 papers receiving 271 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Florian Slimano France 10 104 90 41 40 29 47 274
Alireza Hayatshahi Iran 10 77 0.7× 48 0.5× 18 0.4× 56 1.4× 33 1.1× 24 303
Long Meng China 13 78 0.8× 68 0.8× 33 0.8× 17 0.4× 27 0.9× 31 379
Jill Bates United States 11 100 1.0× 75 0.8× 66 1.6× 43 1.1× 9 0.3× 30 363
Sabrina W. Cole United States 10 111 1.1× 33 0.4× 42 1.0× 92 2.3× 20 0.7× 14 361
Jane M. Pruemer United States 10 75 0.7× 91 1.0× 37 0.9× 57 1.4× 13 0.4× 22 353
Aarthi Iyer United States 10 29 0.3× 85 0.9× 59 1.4× 37 0.9× 20 0.7× 15 411
Marie‐Christine Pérault‐Pochat France 9 83 0.8× 136 1.5× 39 1.0× 57 1.4× 8 0.3× 21 394
Alison Duffy United States 10 30 0.3× 63 0.7× 94 2.3× 38 0.9× 17 0.6× 25 338
Chun‐Feng Wu China 9 94 0.9× 22 0.2× 39 1.0× 34 0.8× 28 1.0× 20 290
Julia Nguyen United States 5 164 1.6× 54 0.6× 19 0.5× 58 1.4× 15 0.5× 8 324

Countries citing papers authored by Florian Slimano

Since Specialization
Citations

This map shows the geographic impact of Florian Slimano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florian Slimano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florian Slimano more than expected).

Fields of papers citing papers by Florian Slimano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florian Slimano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florian Slimano. The network helps show where Florian Slimano may publish in the future.

Co-authorship network of co-authors of Florian Slimano

This figure shows the co-authorship network connecting the top 25 collaborators of Florian Slimano. A scholar is included among the top collaborators of Florian Slimano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florian Slimano. Florian Slimano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Durand, Audrey, et al.. (2025). Overcoming language barriers to enhance pharmaceutical care: Design and validation of a pictogram-based tool for cancer patients. Journal of Oncology Pharmacy Practice. 31(8). 1323–1328.
2.
Perrier, Marine, Éric Bertin, Damien Botsen, et al.. (2025). Impact of low muscle mass and myosteatosis on treatment toxicity and survival outcomes in non-resectable pancreatic cancer patients treated with chemoradiotherapy. European Journal of Clinical Nutrition. 79(6). 576–586. 1 indexed citations
3.
4.
5.
6.
Brügel, Mathias, et al.. (2023). Prevalence of cannabidiol (CBD) consumption and cancer patients’ expectations in one oncology day-hospital: A cross-sectional study and questionnaire validation. Journal of Oncology Pharmacy Practice. 32(1). 3–13. 1 indexed citations
7.
Brügel, Mathias, Zoubir Djerada, Marine Perrier, et al.. (2023). Beta-blocker exposure and survival outcomes in patients with advanced pancreatic ductal adenocarcinoma: a retrospective cohort study (BETAPANC). Frontiers in Pharmacology. 14. 1137791–1137791. 5 indexed citations
8.
Botsen, Damien, Mathias Brügel, Éric Bertin, et al.. (2022). Association of Low Handgrip Strength with Chemotherapy Toxicity in Digestive Cancer Patients: A Comprehensive Observational Cohort Study (FIGHTDIGOTOX). Nutrients. 14(21). 4448–4448. 3 indexed citations
9.
Gower‐Rousseau, Corinne, Damien Botsen, Maxime Hentzien, et al.. (2022). Incidence and associated factors of cetuximab-induced hypersensitivity infusion reactions in 1392 cancer patients treated in four French areas: a possible association with Lyme disease?. BMC Cancer. 22(1). 1219–1219. 6 indexed citations
10.
Maloisel, Frédéric, et al.. (2022). Comparative analysis of rituximab or obinutuzumab combined with CHOP in first-line treatment of follicular lymphoma. Journal of Cancer Research and Clinical Oncology. 149(5). 1883–1893. 3 indexed citations
11.
Mongaret, Céline, et al.. (2021). Safety and Survival Outcomes in Lung Cancer Patients Receiving Carboplatin: Impact of Uncapped Dosage. Chemotherapy. 66(3). 72–77. 2 indexed citations
12.
Slimano, Florian, et al.. (2020). Regards croisés sur la formation du pharmacien d’officine : le point de vue des pharmaciens d’officine, des enseignants et des étudiants en pharmacie. Annales Pharmaceutiques Françaises. 78(3). 242–251. 3 indexed citations
13.
Slimano, Florian, et al.. (2020). Development and validation of a ready-to-use score to prioritise medication reconciliation at patient admission in an orthopaedic and trauma department. European Journal of Hospital Pharmacy. 29(5). 264–270. 5 indexed citations
14.
Mongaret, Céline, et al.. (2020). Freins et leviers à la réalisation des bilans partagés de médication en officine : retour sur une expérimentation dans la région Grand Est. Annales Pharmaceutiques Françaises. 79(2). 119–124. 7 indexed citations
15.
Slimano, Florian, Jérémie Zerbit, Audrey Thomas‐Schoemann, et al.. (2020). Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines). Cancer Treatment Reviews. 88. 102063–102063. 33 indexed citations
16.
Mongaret, Céline, Thi Ha Vo, Pierrick Bedouch, et al.. (2018). Predictive factors for clinically significant pharmacist interventions at hospital admission. Medicine. 97(9). e9865–e9865. 34 indexed citations
17.
Gervais, Frédéric, et al.. (2018). Pharmacists’ interventions on prescription problems in one French community pharmacy: A prospective pilot study. Annales Pharmaceutiques Françaises. 76(4). 299–305. 10 indexed citations
18.
Botsen, Damien, Coralie Barbe, Camille Mazza, et al.. (2018). Dynapenia could predict chemotherapy-induced dose-limiting neurotoxicity in digestive cancer patients. BMC Cancer. 18(1). 955–955. 27 indexed citations
19.
Slimano, Florian, Florence Netzer, Isabelle Borget, François Lemare, & Benjamin Besse. (2018). Olanzapine as antiemetic drug in oncology: a retrospective study in non-responders to standard antiemetic therapy. International Journal of Clinical Pharmacy. 40(5). 1265–1271. 3 indexed citations
20.
Slimano, Florian, et al.. (2016). Actualités dans la prévention et la prise en charge du mélanome : implications et enjeux pour le pharmacien. Annales Pharmaceutiques Françaises. 74(5). 335–349. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alireza Hayatshahi Breakdown of academic impact, for papers by Long Meng Breakdown of academic impact, for papers by Jill Bates Breakdown of academic impact, for papers by Sabrina W. Cole Breakdown of academic impact, for papers by Jane M. Pruemer Breakdown of academic impact, for papers by Aarthi Iyer Breakdown of academic impact, for papers by Marie‐Christine Pérault‐Pochat Breakdown of academic impact, for papers by Alison Duffy Breakdown of academic impact, for papers by Chun‐Feng Wu Breakdown of academic impact, for papers by Julia Nguyen
Rankless by CCL
2026